Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis.

被引：0
|
作者：
Liang, C. [1 ]
Famure, O. [1 ]
Li, Y. [1 ]
Kim, J. [1 ]
机构：
[1] Univ Toronto, Toronto Gen Hosp, Multiorgan Transplant Program, Toronto, ON M5G 1L7, Canada
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：319 / 319
页数：1
相关论文
共 50 条
  • [1] Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis
    Liang, Xinyun
    Famure, Olusegun
    Li, Yanhong
    Kim, S. Joseph
    [J]. PROGRESS IN TRANSPLANTATION, 2018, 28 (02) : 124 - 133
  • [2] Incidence of Cytomegalovirus in Moderate Risk Kidney Transplant Recipients Receiving Low Dose Valganciclovir.
    Fallah, T.
    Logan, A.
    Garcia, L. Beltran
    Bowman, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 722 - 722
  • [3] Risk Factors for Leukopenia with Valganciclovir Prophylaxis in CMV High Risk Cardiothoracic Transplant Recipients
    Brueckner, A. J.
    Doligalski, C. T.
    Logan, A. T.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S365 - S366
  • [4] Expanded valganciclovir prophylaxis in kidney transplant recipients is associated with lower incidence of cytomegalovirus infection
    Veceric-Haler, Zeljka
    Bizjak, Bostjan
    Romozi, Karmen
    Arnol, Miha
    [J]. CLINICAL NEPHROLOGY, 2017, 88 : S126 - S130
  • [5] EXTENDING VALGANCICLOVIR PROPHYLAXIS IN KIDNEY TRANSPLANT RECIPIENTS IS ASSOCIATED WITH LOWER INCIDENCE OF CYTOMEGALOVIRUS INFECTION
    Bizjak, Bostjan
    Veceric-Haler, Zeljka
    Romozi, Karmen
    Arnol, Miha
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 407 - 407
  • [6] Increased Incidence of Cytomegalovirus Infection in High-Risk Liver Transplant Recipients Receiving Valganciclovir Prophylaxis Versus Ganciclovir Prophylaxis
    Shiley, Kevin T.
    Gasink, Leanne B.
    Barton, Todd D.
    Pfeiffenberger, Patrice
    Olthoff, Kim M.
    Blumberg, Emily A.
    [J]. LIVER TRANSPLANTATION, 2009, 15 (08) : 963 - 967
  • [7] Decreased incidence of cytomegalovirus infection in thymoglobulin treated kidney transplant patients with 6 months valganciclovir prophylaxis.
    Akalin, E
    Bromberg, JS
    Sehgal, V
    Ames, S
    Daly, L
    Murphy, B
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 427A - 427A
  • [8] Trough ganciclovir concentration as predictor of leukopenia in lung transplant recipients receiving valganciclovir prophylaxis
    Katada, Yoshiki
    Nakagawa, Shunsaku
    Nagao, Miki
    Umemura, Keisuke
    Itohara, Kotaro
    Nishikawa, Asami
    Hashi, Sachiyo
    Katsube, Yurie
    Hira, Daiki
    Ohsumi, Akihiro
    Nakajima, Daisuke
    Date, Hiroshi
    Terada, Tomohiro
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (06)
  • [9] Valganciclovir for cytomegalovirus prophylaxis in liver transplant recipients
    Park, Jeong M.
    Lake, Kathleen D.
    Fontana, Robert J.
    [J]. LIVER TRANSPLANTATION, 2006, 12 (06) : 1022 - 1023
  • [10] Incidence of valganciclovir-related leukopenia and neutropenia in solid organ transplant recipients at high risk of cytomegalovirus disease
    Belga, Sara
    Hernandez, Cristina
    Kabbani, Dima
    Cervera, Carlos
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (02)
12345